Chez les personnes avec diabète de type 2 à risque cardiovasculaire élevé, est-ce que le sémaglutide oral est efficace et sécuritaire pour diminuer les évènements cardiovasculaires majeurs comparativement au placébo ?

IF 0.9 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Revue De Medecine Interne Pub Date : 2025-05-20 DOI:10.1016/j.revmed.2025.05.010

Alexandre Mutchmore , Mathieu Labossière , Michel Cauchon , Marc-Émile Plourde , Luc Lanthier

引用次数: 0

查看原文本刊更多论文

对于心血管事件高风险的2型糖尿病患者，与安慰剂相比，口服西马鲁肽是否能降低主要不良心血管事件的风险，它是否安全？］

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revue De Medecine Interne 医学-医学：内科

CiteScore

0.70

自引率

11.10%

发文量

526

审稿时长

37 days

期刊介绍： Official journal of the SNFMI, La revue de medecine interne is indexed in the most prestigious databases. It is the most efficient French language journal available for internal medicine specialists who want to expand their knowledge and skills beyond their own discipline. It is also the main French language international medium for French research works. The journal publishes each month editorials, original articles, review articles, short communications, etc. These articles address the fundamental and innumerable facets of internal medicine, spanning all medical specialties. Manuscripts may be submitted in French or in English. La revue de medecine interne also includes additional issues publishing the proceedings of the two annual French meetings of internal medicine (June and December), as well as thematic issues.